These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 19241077

  • 1. The alpha1-adrenergic receptor antagonists, benoxathian and prazosin, induce apoptosis and a switch towards megakaryocytic differentiation in human erythroleukemia cells.
    Fuchs R, Stelzer I, Haas HS, Leitinger G, Schauenstein K, Sadjak A.
    Ann Hematol; 2009 Oct; 88(10):989-97. PubMed ID: 19241077
    [Abstract] [Full Text] [Related]

  • 2. α1-Adrenergic drugs modulate differentiation and cell death of human erythroleukemia cells through non adrenergic mechanism.
    Fuchs R, Schraml E, Leitinger G, Stelzer I, Allard N, Haas HS, Schauenstein K, Sadjak A.
    Exp Cell Res; 2011 Oct 01; 317(16):2239-51. PubMed ID: 21781962
    [Abstract] [Full Text] [Related]

  • 3. α1-adrenergic drugs exhibit affinity to a thapsigargin-sensitive binding site and interfere with the intracellular Ca2+ homeostasis in human erythroleukemia cells.
    Fuchs R, Schraml E, Leitinger G, Letofsky-Papst I, Stelzer I, Haas HS, Schauenstein K, Sadjak A.
    Exp Cell Res; 2011 Dec 10; 317(20):2969-80. PubMed ID: 21851819
    [Abstract] [Full Text] [Related]

  • 4. Levels of Smad7 regulate Smad and mitogen activated kinases (MAPKs) signaling and controls erythroid and megakaryocytic differentiation of erythroleukemia cells.
    Akel S, Bertolette D, Petrow-Sadowski C, Ruscetti FW.
    Platelets; 2007 Dec 10; 18(8):566-78. PubMed ID: 18041647
    [Abstract] [Full Text] [Related]

  • 5. A proteomic approach to the identification of molecular targets in subsequent apoptosis of HEL cells after diosgenin-induced megakaryocytic differentiation.
    Cailleteau C, Liagre B, Beneytout JL.
    J Cell Biochem; 2009 Jul 01; 107(4):785-96. PubMed ID: 19415684
    [Abstract] [Full Text] [Related]

  • 6. Expression of megakaryocytic and erythroid properties in human leukemic cells.
    Tani T, Ylänne J, Virtanen I.
    Exp Hematol; 1996 Feb 01; 24(2):158-68. PubMed ID: 8641337
    [Abstract] [Full Text] [Related]

  • 7. [Effects of prazosin on the proliferation and apoptosis of K562 leukemia cells].
    He J, He Q.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Oct 01; 30(5):562-5. PubMed ID: 16320589
    [Abstract] [Full Text] [Related]

  • 8. Increased cyclooxygenase-2 and thromboxane synthase expression is implicated in diosgenin-induced megakaryocytic differentiation in human erythroleukemia cells.
    Cailleteau C, Liagre B, Battu S, Jayat-Vignoles C, Beneytout JL.
    Anal Biochem; 2008 Sep 01; 380(1):26-34. PubMed ID: 18549804
    [Abstract] [Full Text] [Related]

  • 9. Decursin and PDBu: two PKC activators distinctively acting in the megakaryocytic differentiation of K562 human erythroleukemia cells.
    Kim HH, Ahn KS, Han H, Choung SY, Choi SY, Kim IH.
    Leuk Res; 2005 Dec 01; 29(12):1407-13. PubMed ID: 15992925
    [Abstract] [Full Text] [Related]

  • 10. Differential expression of ras protooncogenes during in vitro differentiation of human erythroleukemia cells.
    Delgado MD, Quincoces AF, Gómez-Casares MT, Martínez CA, Cuadrado MA, Richard C, León J.
    Cancer Res; 1992 Nov 01; 52(21):5979-84. PubMed ID: 1394224
    [Abstract] [Full Text] [Related]

  • 11. Expression of protease activated receptor 3 (PAR3) is upregulated by induction of megakaryocyte phenotype in human erythroleukemia (HEL) cells.
    Cupit LD, Schmidt VA, Gnatenko DV, Bahou WF.
    Exp Hematol; 2004 Oct 01; 32(10):991-9. PubMed ID: 15504554
    [Abstract] [Full Text] [Related]

  • 12. Induced myeloid differentiation of K562 cells with downregulation of erythroid and megakaryocytic transcription factors: a novel experimental model for hemopoietic lineage restriction.
    Green AR, Rockman S, DeLuca E, Begley CG.
    Exp Hematol; 1993 Apr 01; 21(4):525-31. PubMed ID: 8462662
    [Abstract] [Full Text] [Related]

  • 13. Bcl-x is a regulatory factor of apoptosis and differentiation in megakaryocytic lineage cells.
    Terui Y, Furukawa Y, Kikuchi J, Iwase S, Hatake K, Miura Y.
    Exp Hematol; 1998 Mar 01; 26(3):236-44. PubMed ID: 9502620
    [Abstract] [Full Text] [Related]

  • 14. Effects of chebulinic acid on differentiation of human leukemia K562 cells.
    Yi ZC, Wang Z, Li HX, Liu MJ, Wu RC, Wang XH.
    Acta Pharmacol Sin; 2004 Feb 01; 25(2):231-8. PubMed ID: 14769215
    [Abstract] [Full Text] [Related]

  • 15. The close relationship between DNA replication and the selection of differentiation lineages of human erythroleukemia cell lines K562, HEL, and TF1 into either erythroid or megakaryocytic lineages.
    Murate T, Saga S, Hotta T, Asano H, Ito T, Kato K, Tsushita K, Kinoshita T, Ichikawa A, Yoshida S.
    Exp Cell Res; 1993 Sep 01; 208(1):35-43. PubMed ID: 8359227
    [Abstract] [Full Text] [Related]

  • 16. CDDO-Im is a stimulator of megakaryocytic differentiation.
    Petronelli A, Pelosi E, Santoro S, Saulle E, Cerio AM, Mariani G, Labbaye C, Testa U.
    Leuk Res; 2011 Apr 01; 35(4):534-44. PubMed ID: 21035854
    [Abstract] [Full Text] [Related]

  • 17. A plant steroid, diosgenin, a new megakaryocytic differentiation inducer of HEL cells.
    Beneytout JL, Nappez C, Leboutet MJ, Malinvaud G.
    Biochem Biophys Res Commun; 1995 Feb 06; 207(1):398-404. PubMed ID: 7857294
    [Abstract] [Full Text] [Related]

  • 18. Megakaryocyte cell sorting from diosgenin-differentiated human erythroleukemia cells by sedimentation field-flow fractionation.
    Léger DY, Battu S, Liagre B, Beneytout JL, Cardot PJ.
    Anal Biochem; 2006 Aug 01; 355(1):19-28. PubMed ID: 16806034
    [Abstract] [Full Text] [Related]

  • 19. In vitro dual effect of arsenic trioxide on hemopoiesis: inhibition of erythropoiesis and stimulation of megakaryocytic maturation.
    Saulle E, Riccioni R, Pelosi E, Stafness M, Mariani G, De Tuglie G, Peschle C, Testa U.
    Blood Cells Mol Dis; 2006 Aug 01; 36(1):59-76. PubMed ID: 16360329
    [Abstract] [Full Text] [Related]

  • 20. Malignant hematopoietic cell lines: in vitro models for the study of erythroleukemia.
    Drexler HG, Matsuo Y, MacLeod RA.
    Leuk Res; 2004 Dec 01; 28(12):1243-51. PubMed ID: 15475063
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.